Cancers can make themselves harder for new immunotherapies to see by ‘changing their spots’ — and switching off a key molecule on the surface of cells that is otherwise recognised by treatment.
Cancers ‘change spots’ to avoid immunotherapy
Cancers can make themselves harder for new immunotherapies to see by ‘changing their spots’ — and switching off a key molecule on the surface of cells that is otherwise recognised by treatment.